Mpox Outbreak: 5 Things to Know if Patients Ask
Now that the WHO has declared a second mpox global emergency, you may want to brush up on knowledge of the disease and the 2024 outbreak.
Pediatric EoE: FDA Accepts Dupilumab sBLA for Priority Review in Children Younger than 12 Years
Dupilumab, a monoclonal antibody targeting type 2 inflammation, would be the first treatment of its kind for younger children with eosinophilic esophagitis.
Inflammation Associated with Poor Weight Loss Outcomes and Depression After Bariatric Surgery
Elevated inflammation, rather than depression, may drive poor weight loss outcomes in patients with obesity following bariatric surgery, suggest authors of new study.
